ANI PHARMACEUTICALS INC (ANIP) Stock Price, Quote, News and Overview
NASDAQ:ANIP - Nasdaq - US00182C1036 - Common Stock - Currency: USD
ANIP Quote, Performance and Key Statistics
59.53
-0.84 (-1.39%)
The current stock price of ANIP is 59.53 USD. In the past month the price decreased by -13.97%. In the past year, price decreased by -3.09%.
ANIP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 53.29 | 695.15B | ||
| JNJ | JOHNSON & JOHNSON | 14.89 | 359.97B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 19.12 | 293.64B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.05 | 214.22B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.27 | 210.70B | ||
| MRK | MERCK & CO. INC. | 9.6 | 188.23B | ||
| PFE | PFIZER INC | 7.04 | 128.17B | ||
| SNY | SANOFI-ADR | 13.42 | 124.51B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.24 | 93.23B | ||
| GSK | GSK PLC-SPON ADR | 6.89 | 76.02B | ||
| ZTS | ZOETIS INC | 26.64 | 71.53B | ||
| HLN | HALEON PLC-ADR | 22.23 | 48.11B |
Related stock screener links
About ANIP
Company Profile
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. The company is headquartered in Baudette, Minnesota and currently employs 897 full-time employees. The company went IPO on 2000-05-04. Its Rare Disease and Brands segment consists of two reporting units. The Rare Disease unit consists of operations related to the development, manufacturing, and marketing of branded pharmaceutical products, with a focus on products used in the treatment of patients with rare disease conditions and consists of operations related to Cortrophin Gel, ILUVIEN and YUTIQ. In addition, the Brands reporting unit includes a portfolio of over 16 brand products that are principally sold in genericized markets. Its Generics and Other segment consist of operations related to the development, manufacturing, and marketing of generic pharmaceutical products, including those sold through traditional wholesale and retail sales channels, sales of contract manufactured products, royalties on contract manufactured products, product development services, and others.
Company Info
ANI PHARMACEUTICALS INC
210 Main Street West
Baudette MINNESOTA 56623 US
CEO: Nikhil Lalwani
Employees: 897
Phone: 12186343500
ANI PHARMACEUTICALS INC / ANIP FAQ
What is the stock price of ANI PHARMACEUTICALS INC today?
The current stock price of ANIP is 59.53 USD. The price decreased by -1.39% in the last trading session.
What is the ticker symbol for ANI PHARMACEUTICALS INC stock?
The exchange symbol of ANI PHARMACEUTICALS INC is ANIP and it is listed on the Nasdaq exchange.
On which exchange is ANIP stock listed?
ANIP stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ANI PHARMACEUTICALS INC stock?
14 analysts have analysed ANIP and the average price target is 83.06 USD. This implies a price increase of 39.52% is expected in the next year compared to the current price of 59.53. Check the ANI PHARMACEUTICALS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ANI PHARMACEUTICALS INC worth?
ANI PHARMACEUTICALS INC (ANIP) has a market capitalization of 1.28B USD. This makes ANIP a Small Cap stock.
How many employees does ANI PHARMACEUTICALS INC have?
ANI PHARMACEUTICALS INC (ANIP) currently has 897 employees.
What are the support and resistance levels for ANI PHARMACEUTICALS INC (ANIP) stock?
ANI PHARMACEUTICALS INC (ANIP) has a support level at 56.06. Check the full technical report for a detailed analysis of ANIP support and resistance levels.
Is ANI PHARMACEUTICALS INC (ANIP) expected to grow?
The Revenue of ANI PHARMACEUTICALS INC (ANIP) is expected to grow by 30.55% in the next year. Check the estimates tab for more information on the ANIP EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ANI PHARMACEUTICALS INC (ANIP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ANIP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ANIP, evaluating the profitability, health, valuation and growth aspects
- ANI PHARMACEUTICALS INC (ANIP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ANI PHARMACEUTICALS INC (ANIP) Sales and EPS estimates to see what analysts future expectations are.
- ANI PHARMACEUTICALS INC (ANIP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ANI PHARMACEUTICALS INC (ANIP) Insider and Institutional Ownership to learn about the owners and their transactions.
- ANI PHARMACEUTICALS INC (ANIP) Stock Chart to make your own analysis
- ANI PHARMACEUTICALS INC (ANIP) Latest news and press-releases to stay up to date.
Does ANI PHARMACEUTICALS INC (ANIP) stock pay dividends?
ANIP does not pay a dividend.
When does ANI PHARMACEUTICALS INC (ANIP) report earnings?
ANI PHARMACEUTICALS INC (ANIP) will report earnings on 2025-08-04, before the market open.
What is the Price/Earnings (PE) ratio of ANI PHARMACEUTICALS INC (ANIP)?
The PE ratio for ANI PHARMACEUTICALS INC (ANIP) is 10.46. This is based on the reported non-GAAP earnings per share of 5.69 and the current share price of 59.53 USD. Check the full fundamental report for a full analysis of the valuation metrics for ANIP.
What is the Short Interest ratio of ANI PHARMACEUTICALS INC (ANIP) stock?
The outstanding short interest for ANI PHARMACEUTICALS INC (ANIP) is 11.11% of its float. Check the ownership tab for more information on the ANIP short interest.
ANIP Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ANIP. When comparing the yearly performance of all stocks, ANIP turns out to be only a medium performer in the overall market: it outperformed 48.06% of all stocks.
ANIP Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ANIP. ANIP has only an average score on both its financial health and profitability.
ANIP Financial Highlights
Over the last trailing twelve months ANIP reported a non-GAAP Earnings per Share(EPS) of 5.69. The EPS increased by 19.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.3% | ||
| ROE | -0.9% | ||
| Debt/Equity | 1.43 |
ANIP Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to ANIP. The Buy consensus is the average rating of analysts ratings from 14 analysts.
For the next year, analysts expect an EPS growth of 23.99% and a revenue growth 30.55% for ANIP